By staff writers

March 4, 2014 -- Canadian radioisotope firm Nordion and Bracco Imaging have signed a two-year contract to supply U.S. subsidiary Bracco Diagnostics with strontium-82.

The medical isotope is produced at both Nordion's Vancouver, British Columbia, and Ottawa, Ontario, facilities.

Strontium-82 is used in Bracco's CardioGen-82 generators and decays over time into the medical isotope rubidium-82.

Rubidium-82 chloride injection is used in PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.

Copyright © 2014

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking